Tickers — D

66 tickers
Ranks this page's recent reports by score.
Dorman Products, Inc.
DORM·Consumer Discretionary
B ★★★Hold
Current$132.82
Target$141.05
Return+6.2%
Aug 19, 2026

Dorman Products is a highly profitable, asset-light tollbooth on the aging U.S. vehicle fleet, boasting pristine ROIC and free cash flow, though investors must remain cautious of heavy customer concentration and persistent geopolitical supply-chain risks.

Score
77
Dianthus Therapeutics, Inc.
DNTH·Healthcare
B ★★★Hold
Current$116.00
Target$138.00
Return+19.0%
Aug 18, 2026

Dianthus is a masterfully capitalized, best-in-class biotech poised to disrupt the multi-billion dollar autoimmune market with highly selective, convenient complement inhibitors, though its parabolic valuation demands flawless execution in upcoming late-stage clinical readouts.

Score
78
Definium Therapeutics, Inc.
DFTX·Healthcare
A ★★★★Buy
Current$42.63
Target$73.00
Return+71.2%
Aug 18, 2026

Definium Therapeutics is poised to revolutionize psychiatric care with its de-risked Phase 3 psychedelic candidate DT120, backed by a formidable $1.1 billion cash runway, though investors must navigate the execution risks of regulatory approval and commercial rollout.

Score
87
Dillard's, Inc.
DDS·Consumer Discretionary
B ★★★Hold
Current$560.88
Target$546.00
Return-2.7%
Aug 16, 2026

Dillard's operates as a debt-free, cash-printing fortress that continuously enriches shareholders through massive special dividends and buybacks, though investors must accept stagnant top-line revenue inside a secularly declining department store sector.

Score
81
Diageo plc
DEO·Consumer Staples
B ★★★Hold
Current$95.44
Target$109.95
Return+15.2%
Aug 16, 2026

Diageo offers a rare opportunity to acquire the world's premier portfolio of heritage spirits at a deeply distressed multiple, though investors must remain hyper-vigilant regarding the long-term impact of generational shifts in alcohol consumption and the protracted U.S. inventory correction.

Score
83
Amdocs Limited
DOX·Technology
A ★★★★Buy
Current$58.66
Target$81.62
Return+39.1%
Aug 16, 2026

Amdocs is an impenetrable, highly cash-generative tollbooth for global telecom operations trading at a deeply distressed valuation, though investors must accept stagnant top-line growth tied to constrained carrier capital expenditures.

Score
86
Dave Inc.
DAVE·Financials
B ★★★Hold
Current$316.19
Target$372.40
Return+17.8%
Aug 15, 2026

Dave disrupts traditional banking with high-margin neobank services and AI underwriting, though regulatory scrutiny and a premium valuation warrant caution despite explosive growth.

Score
81
Denali Therapeutics Inc.
DNLI·Healthcare
B ★★★Hold
Current$25.09
Target$35.00
Return+39.5%
Aug 13, 2026

Denali Therapeutics holds a first-mover advantage with its FDA-validated blood-brain barrier transport platform, but the recent Parkinson's and ALS trial failures alongside a steep valuation premium warrant a cautious hold pending further clinical de-risking.

Score
75
Dropbox, Inc.
DBX·Technology
B ★★★Hold
Current$34.59
Target$39.65
Return+14.6%
Aug 12, 2026

Dropbox is a highly efficient, cash-printing utility trading at a distressed 11.4x forward multiple that provides a massive margin of safety, but investors must remain highly vigilant regarding stagnant 0.9% revenue growth, escalating debt burdens, and intense competitive bundling from Microsoft and Google.

Score
79
Darling Ingredients Inc.
DAR·Consumer Staples
A ★★★★Buy
Current$59.41
Target$77.22
Return+30.0%
Aug 12, 2026

Darling Ingredients leverages an impenetrable waste-rendering moat into high-growth renewable fuels and specialty collagen, trading at a heavily discounted valuation while investors await impending regulatory clarity on the 45Z tax credit.

Score
87
Leonardo DRS, Inc.
DRS·Industrials
C ★★Sell
Current$44.80
Aug 10, 2026

Leonardo DRS is a highly profitable, wide-moat architect of naval electrification and tactical defense systems trading at an excessively rich premium, where record backlog growth is heavily overshadowed by aggressive insider selling and critical, immediate vulnerability to Chinese supply chain embargoes.

Score
66
Dynatrace, Inc.
DT·Technology
S ★★★★★Strong Buy
Current$48.97
Target$65.00
Return+32.7%
Aug 11, 2026

Dynatrace is a deeply undervalued, highly profitable tollbooth for the AI and hybrid-cloud era, fortified by activist-driven margin expansion and a massive share buyback program, though it must successfully navigate a pending CFO transition and relentless competition from Datadog.

Score
100
Driven Brands Holdings Inc.
DRVN·Consumer Discretionary
B ★★★Hold
Current$13.33
Target$17.50
Return+31.3%
Aug 10, 2026

Driven Brands is a highly cash-generative, recession-resistant automotive consolidator trading at a deeply distressed valuation due to a largely resolved accounting scandal, though investors must tolerate lingering litigation overhangs and near-term macroeconomic pressure on consumer traffic.

Score
77
DraftKings Inc.
DKNG·Consumer Discretionary
B ★★★Hold
Current$24.03
Target$32.20
Return+34.0%
Aug 9, 2026

DraftKings commands a dominant position in the expanding US sports betting market, but rising state taxes and near-term competitive headwinds limit immediate upside.

Score
76
Datadog, Inc.
DDOG·Technology
B ★★★Hold
Current$235.50
Target$277.20
Return+17.7%
Aug 9, 2026

Datadog is the undisputed, highly profitable apex predator of cloud and AI observability, but its priced-for-perfection 93x forward multiple leaves it highly vulnerable to near-term multiple compression driven by enterprise telemetry optimization cycles.

Score
76
DoorDash, Inc.
DASH·Consumer Discretionary
B ★★★Hold
Current$207.27
Target$245.00
Return+18.2%
Aug 8, 2026

DoorDash has successfully monopolized US suburban logistics and proven explosive cash flow generation, but its oxygen-deprived valuation leaves it highly vulnerable to minimum-wage gig-economy legislation and broad multiple compression.

Score
77
Duolingo, Inc.
DUOL·Technology
B ★★★Hold
Current$137.75
Target$154.44
Return+12.1%
Aug 8, 2026

Duolingo is the undisputed, highly profitable apex predator of digital education, fortified by a globally addictive gamification moat and an elite Birdbrain algorithm, though its aggressive forward multiple leaves it highly vulnerable to near-term growth deceleration and the looming threat of native AI chatbots.

Score
78
The Walt Disney Company
DIS·Communication Services
B ★★★Hold
Current$104.63
Target$127.50
Return+21.9%
Aug 8, 2026

Disney presents a compelling turnaround narrative with streaming finally reaching operating profitability and a powerful $9 billion buyback floor, though investors must exercise patience as the company navigates the turbulent structural decay of its legacy linear TV segments and near-term macroeconomic headwinds at domestic parks.

Score
76
Duke Energy Corporation
DUK·Utilities
B ★★★Hold
Current$123.86
Target$134.00
Return+8.2%
Aug 7, 2026

Duke Energy is a flawless, cash-generating monopoly perfectly positioned to capitalize on the generational AI data center and electrification supercycle, though its massive debt load and fully priced valuation require patience for the ideal entry point.

Score
82
DuPont de Nemours, Inc.
DD·Materials
C ★★Sell
Current$147.37
Aug 7, 2026

DuPont has successfully transformed into a high-margin, cash-rich water and healthcare technology pure-play, but its premium valuation multiple and perpetual, multi-billion-dollar PFAS litigation overhang make the stock too dangerous to hold at current elevated prices.

Score
65
Devon Energy Corporation
DVN·Energy
A ★★★★Buy
Current$43.11
Target$64.88
Return+50.5%
Aug 7, 2026

Devon Energy presents a profoundly mispriced cash-flow compounder shielded by a fortress balance sheet and massive Coterra-driven synergies, though its long-term trajectory remains permanently tethered to the inescapable cyclicality of global crude oil demand.

Score
90
DaVita Inc.
DVA·Healthcare
B ★★★Hold
Current$188.69
Target$210.00
Return+11.3%
Aug 7, 2026

DaVita is a cash-printing, highly efficient duopoly operator relentlessly shrinking its float to drive EPS, but investors must remain hyper-vigilant regarding the existential threats of commercial reimbursement compression, Medicare Advantage penetration, and long-term volumetric declines driven by GLP-1 adoption.

Score
77
DigitalOcean Holdings, Inc.
DOCN·Technology
B ★★★Hold
Current$128.89
Target$158.00
Return+22.6%
Aug 6, 2026

DigitalOcean is successfully transforming from a simple SMB host into a highly profitable, AI-native inference powerhouse with unstoppable backlog momentum, though its eye-watering 51x forward multiple leaves it fully priced for perfection.

Score
80
DT Midstream, Inc.
DTM·Energy
B ★★★Hold
Current$138.00
Target$155.00
Return+12.3%
Aug 5, 2026

DT Midstream is a fundamentally pristine, highly contracted natural gas tollbooth perfectly poised to benefit from generational LNG and AI power demand, but its extreme 30x valuation multiple leaves investors with absolutely zero margin of safety against execution or regulatory delays.

Score
75